"10.1371_journal.pone.0147581","plos one","2016-01-22T00:00:00Z","Dominic Ehrmann; Nikola Bergis-Jurgan; Thomas Haak; Bernhard Kulzer; Norbert Hermanns","Research Institute of the Diabetes Academy Mergentheim (FIDAM), Johann Hammer-Str. 24, 97980, Bad Mergentheim, Germany; Diabetes Centre Mergentheim, Diabetes Clinic, Theodor-Klotzbuecher-Str. 12, 97980, Bad Mergentheim, Germany; Otto-Friedrich-University of Bamberg, Department of Clinical Psychology and Psychotherapy, Bamberg, Germany","Conceived and designed the experiments: DE NBJ TH BK NH. Performed the experiments: DE NBJ. Analyzed the data: DE NH. Contributed reagents/materials/analysis tools: DE NBJ TH BK NH. Wrote the paper: DE NH. Revised manuscript critically for important intellectual content: DE NBJ TH BK NH. Final approval of the version to be published: DE NBJ TH BK NH.","The development and evaluation of PRIMAS was supported by an unrestricted grant of Berlin-Chemie AG/Menarini Diagnostics, Germany. The funders had no role in the conceptualisation of PRIMAS, study design, data collection and analysis, interpretation of data, decision to publish, or preparation and writing of the manuscript. BERLIN-CHEMIE develops, produces and sells pharmaceutical products and is a German subsidiary of the MENARINI Group. None of the authors is or has been an employee of either Berlin-Chemie or Menarini Diagnostics. All authors have received honoraria for lectures from Berlin-Chemie. D.E., N.H., B.K. and T.H. have received honoraria for consultancy. None of the authors is involved in patents, products in development, or marketed products of Berlin-Chemie or Menarini Diagnostics. The authors declare no other financial, non-financial, professional or personal competing interests. D.E., N.H., and B.K. take responsibility for the integrity of the work as a whole, from inception to published article. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Dominic Ehrmann","DE",5,TRUE,5,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
